Skibsbye Lasse, Jespersen Thomas, Christ Torsten, Maleckar Mary M, van den Brink Jonas, Tavi Pasi, Koivumäki Jussi T
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Germany; DZ HK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck,Germany.
J Mol Cell Cardiol. 2016 Dec;101:26-34. doi: 10.1016/j.yjmcc.2016.10.009. Epub 2016 Oct 20.
Refractoriness of cardiac cells limits maximum frequency of electrical activity and protects the heart from tonic contractions. Short refractory periods support major arrhythmogenic substrates and augmentation of refractoriness is therefore seen as a main mechanism of antiarrhythmic drugs. Cardiomyocyte excitability depends on availability of sodium channels, which involves both time- and voltage-dependent recovery from inactivation. This study therefore aims to characterise how sodium channel inactivation affects refractoriness in human atria.
Steady-state activation and inactivation parameters of sodium channels measured in vitro in isolated human atrial cardiomyocytes were used to parameterise a mathematical human atrial cell model. Action potential data were acquired from human atrial trabeculae of patients in either sinus rhythm or chronic atrial fibrillation. The ex vivo measurements of action potential duration, effective refractory period and resting membrane potential were well-replicated in simulations using this new in silico model. Notably, the voltage threshold potential at which refractoriness was observed was not different between sinus rhythm and chronic atrial fibrillation tissues and was neither affected by changes in frequency (1 vs. 3Hz).
Our results suggest a preferentially voltage-dependent, rather than time-dependent, effect with respect to refractoriness at physiologically relevant rates in human atria. However, as the resting membrane potential is hyperpolarized in chronic atrial fibrillation, the voltage-dependence of excitability dominates, profoundly increasing the risk for arrhythmia re-initiation and maintenance in fibrillating atria. Our results thereby highlight resting membrane potential as a potential target in pharmacological management of chronic atrial fibrillation.
心肌细胞的不应期限制了电活动的最大频率,并保护心脏免受强直性收缩。短不应期支持主要的致心律失常基质,因此不应期的延长被视为抗心律失常药物的主要作用机制。心肌细胞的兴奋性取决于钠通道的可用性,这涉及从失活状态的时间和电压依赖性恢复。因此,本研究旨在表征钠通道失活如何影响人类心房的不应期。
在体外分离的人类心房心肌细胞中测量的钠通道稳态激活和失活参数,用于参数化一个数学化的人类心房细胞模型。动作电位数据取自窦性心律或慢性心房颤动患者的人类心房小梁。使用这个新的计算机模型进行模拟,很好地复制了动作电位持续时间、有效不应期和静息膜电位的离体测量结果。值得注意的是,窦性心律和慢性心房颤动组织中观察到不应期的电压阈值电位没有差异,也不受频率变化(1Hz对3Hz)的影响。
我们的结果表明,在人类心房生理相关频率下,不应期优先依赖电压而非时间。然而,由于慢性心房颤动时静息膜电位超极化,兴奋性的电压依赖性占主导,显著增加了颤动心房中心律失常重新启动和维持的风险。我们的结果因此突出了静息膜电位作为慢性心房颤动药物治疗潜在靶点的地位。